Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection.

Trial Profile

Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Feb 2016

At a glance

  • Drugs Retapamulin (Primary)
  • Indications Eczema; Folliculitis; Impetigo; Methicillin-resistant Staphylococcus aureus infections; Soft tissue infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jan 2016 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
    • 16 Feb 2012 Planned end date changed from 1 Apr 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
    • 21 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top